DK0579830T3 - Terapeutisk middel til hornhindebeskadigelse - Google Patents

Terapeutisk middel til hornhindebeskadigelse

Info

Publication number
DK0579830T3
DK0579830T3 DK91919156.9T DK91919156T DK0579830T3 DK 0579830 T3 DK0579830 T3 DK 0579830T3 DK 91919156 T DK91919156 T DK 91919156T DK 0579830 T3 DK0579830 T3 DK 0579830T3
Authority
DK
Denmark
Prior art keywords
therapeutic agent
corneal
activity
lactoperoxidase
growth
Prior art date
Application number
DK91919156.9T
Other languages
English (en)
Inventor
Shiro Mita
Mitsushi Hikida
Michel Francois Degre
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0579830T3 publication Critical patent/DK0579830T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91919156.9T 1990-11-13 1991-11-08 Terapeutisk middel til hornhindebeskadigelse DK0579830T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30803690 1990-11-13

Publications (1)

Publication Number Publication Date
DK0579830T3 true DK0579830T3 (da) 1997-08-18

Family

ID=17976118

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919156.9T DK0579830T3 (da) 1990-11-13 1991-11-08 Terapeutisk middel til hornhindebeskadigelse

Country Status (9)

Country Link
US (1) US5561109A (da)
EP (1) EP0579830B1 (da)
JP (1) JP2840795B2 (da)
AT (1) ATE148631T1 (da)
DE (1) DE69124627T2 (da)
DK (1) DK0579830T3 (da)
ES (1) ES2096663T3 (da)
GR (1) GR3023080T3 (da)
WO (1) WO1992008477A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07196529A (ja) * 1993-12-29 1995-08-01 Morinaga Milk Ind Co Ltd 創傷治癒剤、化粧料および養毛剤
JP3118584B2 (ja) * 1995-05-08 2000-12-18 参天製薬株式会社 術後乱視予防剤
JPH1149698A (ja) 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd 安定性を向上させたラクトフェリンの水性製剤
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US20030203839A1 (en) * 1999-10-29 2003-10-30 Kruzel Marian L. Immune enhancing composition containing lactoferrin
US6613741B2 (en) * 1999-10-29 2003-09-02 Ferro Dynamics, Inc. Method for treating aseptic SIRS in humans and other animals
WO2001091779A1 (fr) * 2000-05-29 2001-12-06 Wakamoto Pharmaceutical Co., Ltd. Remedes contre les lesions corneennes
SE0200667D0 (sv) * 2002-03-05 2002-03-05 A & Science Invest Ab Novel use of cytokine inhibitors
DE60335997D1 (de) * 2002-09-16 2011-03-24 Agennix Inc Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
EP1581243A4 (en) * 2002-12-06 2008-01-02 Agennix Inc ORAL LACTOFERRINE FOR THE TREATMENT OF SEPSIES
US7323443B2 (en) * 2002-12-12 2008-01-29 Agennix Inc. Lactoferrin in the reduction of pain
US7282202B2 (en) 2003-02-24 2007-10-16 Morinaga Milk Industry Co., Ltd. Interleukin-6 suppressive agent
JP3946747B2 (ja) 2004-02-17 2007-07-18 森永乳業株式会社 ラクトパーオキシダーゼの製造方法
US20070059300A1 (en) * 2005-09-12 2007-03-15 Zoltan Laboratories Llc Compounds and compositions to control abnormal cell growth
EP1942928A2 (en) * 2005-10-31 2008-07-16 Essential Skincare, LLC Protein composition for promoting wound healing and skin regeneration
CN103037894A (zh) * 2010-07-01 2013-04-10 华柏恩视觉研究中心 创伤治疗的乳铁蛋白序列、组合物及方法
EP3829566A2 (en) 2018-07-27 2021-06-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460135A1 (fr) * 1979-07-02 1981-01-23 Liotet Serge Composition a usage externe a base de colostrum
LU85479A1 (fr) * 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
US4745100A (en) * 1985-05-14 1988-05-17 Eye Research Institute Of Retina Foundation Stimulation of tear secretion
FR2600250B1 (fr) * 1986-06-23 1989-11-24 Bio Serae Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
JPH0248534A (ja) * 1988-07-28 1990-02-19 Bio Serae Sa:Soc 抗菌組成物の配合方法及び配合された抗菌組成物

Also Published As

Publication number Publication date
ES2096663T3 (es) 1997-03-16
WO1992008477A1 (en) 1992-05-29
EP0579830A4 (en) 1993-10-06
EP0579830B1 (en) 1997-02-05
DE69124627T2 (de) 1997-06-12
DE69124627D1 (de) 1997-03-20
EP0579830A1 (en) 1994-01-26
GR3023080T3 (en) 1997-07-30
ATE148631T1 (de) 1997-02-15
JP2840795B2 (ja) 1998-12-24
US5561109A (en) 1996-10-01

Similar Documents

Publication Publication Date Title
DK0579830T3 (da) Terapeutisk middel til hornhindebeskadigelse
DE69531104D1 (de) Transdermales system zur verabreichung durch entepithelisierte haut
ATE361093T1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DK157689A (da) Farmaceutiske piroxicammidler i vandige oploesninger samt fremgangsmaade til fremstilling heraf
EE9900428A (et) Köhavastased ravimkoostised
BR9007115A (pt) Novo trombolitico
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
ATE167060T1 (de) Epidermis-wachstumsfaktor als arzneimittel zur wiederherstellung der neuronen der substantia nigra in der behandlung nervenzerstörender störungen
DE3784628D1 (de) Dermale behandlung von wurmerkrankungen der katze mit praziquantel.
EP0373771A3 (en) New pharmaceutical uses for cystatins
ATE126063T1 (de) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen.
DE69024060D1 (de) Osteogenesis-stimulierende mittel.
KR940007059A (ko) 변형된 혈소판 인자-4
ATE224727T1 (de) Faktor xiii zur behandlung von hautwunden
NO890801D0 (no) Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.
ES2073245T3 (es) Agentes para el tratamiento de la cornea.
ATE175213T1 (de) Ch0ndromodulin-ii protein
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DE69325512D1 (de) Verwendung von remacemid zur behandlung des morbus parkinson
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ES2009146A6 (es) Procedimiento de obtencion de una solucion aminopeptidica de origen animal por procesos enzimaticos
DE69833317D1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
IT8609534A0 (it) Preparato,in particolare collirio o pomata,per il trattamento di alterazioni distrofiche e vascolari dei tessuti oculari.